Latest period
$170.70M
YoY change
+21.6%
5Y CAGR
+17.5%
Peak year (2023)
$180.70M
Latest annual
$177.70M
Stock-Based Compensation history chart for Viatris (VTRS) from 2003 to 2025
Latest: $177.70M
Stock-Based Compensation growth chart for Viatris (VTRS) from 2003 to 2025
Latest: +21.6%
Stock-Based Compensation history table for Viatris (VTRS) from 2003 to 2025
| 2025 | $177.70M | +21.6% | +$31.60M | ||
| 2024 | $146.10M | -19.1% | −$34.60M | ||
| 2023 | $180.70M | +55.2% | +$64.30M | ||
| 2022 | $116.40M | +4.7% | +$5.20M | ||
| 2021 | $111.20M | +40.4% | +$32.00M | ||
| 2020 | $79.20M | +39.4% | +$22.40M | ||
| 2019 | $56.80M | -19.5% | −$13.80M | ||
| 2018 | $70.60M | -5.5% | −$4.10M | ||
| 2017 | $74.70M | -16.0% | −$14.20M | ||
| 2016 | $88.90M | -4.2% | −$3.90M | ||
| 2015 | $92.80M | +40.6% | +$26.80M | ||
| 2014 | $66.00M | +40.4% | +$19.00M | ||
| 2013 | $47.00M | — | +$47.00M | ||
| 2012 | $0.00 | — | $0.00 | ||
| 2011 | $0.00 | — | $0.00 | ||
| 2010 | $0.00 | — | $0.00 | ||
| 2009 | $0.00 | — | $0.00 | ||
| 2008 | $0.00 | — | $0.00 | ||
| 2007 | $0.00 | — | — | ||
| 2005 | $0.00 | — | $0.00 | ||
| 2004 | $0.00 | — | $0.00 | ||
| 2003 | $0.00 | — | — |
- 2025$177.70M+21.6%
- 2024$146.10M-19.1%
- 2023$180.70M+55.2%
- 2022$116.40M+4.7%
- 2021$111.20M+40.4%
- 2020$79.20M+39.4%
- 2019$56.80M-19.5%
- 2018$70.60M-5.5%
- 2017$74.70M-16.0%
- 2016$88.90M-4.2%
- 2015$92.80M+40.6%
- 2014$66.00M+40.4%
- 2013$47.00M—
- 2012$0.00—
- 2011$0.00—
- 2010$0.00—
- 2009$0.00—
- 2008$0.00—
- 2007$0.00—
- 2005$0.00—
- 2004$0.00—
- 2003$0.00—
Stock-Based Compensation values are taken from Viatris's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Viatris (VTRS)
Stock-Based Compensation for Viatris (VTRS): headline value $170.70M · YoY +21.6%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Viatris (VTRS) reported stock-based compensation of $177.70M – grew 21.6% year-over-year.
Through 2020–2025 (5 years), Viatris stock-based compensation delivered a +17.5% annualised rate; with mixed annual results across the window.
The record annual stock-based compensation stands at $180.70M, reached in 2023; the historical low of $0.00 was recorded in 2003.
Viatris Stock-Based Compensation by Year
Viatris Stock-Based Compensation 2025: $177.70M
Viatris posted stock-based compensation of $177.70M in 2025, grew 21.6% from 2024.
Viatris Stock-Based Compensation 2024: $146.10M
In 2024, Viatris reported stock-based compensation of $146.10M, declined 19.1% below 2023.
Viatris Stock-Based Compensation 2023: $180.70M
Viatris stock-based compensation in 2023 was $180.70M, surged 55.2% from 2022. This figure represents the highest annual value in the available history.
Viatris Stock-Based Compensation 2022: $116.40M
2022's stock-based compensation for Viatris came in at $116.40M, edged up 4.7% from 2021.
Viatris Stock-Based Compensation 2021: $111.20M
Viatris stock-based compensation in 2021 was $111.20M.
See more financial history for Viatris (VTRS).
Sector peers by Stock-Based Compensation
Healthcare peers of Viatris (VTRS), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
Viatris (VTRS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation